Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

135
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
135
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

93
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
93
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

99
The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration,...
99
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

128
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
128
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

104
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
104
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

73
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standard knee radiographs enable deep learning inference of MRI-defined cartilage and meniscal damage in early knee osteoarthritis: a study using the osteoarthritis initiative database.

Frontiers in physiology·2026
Same author

Estimating the risk of cancer with and without a screening history.

Lifetime data analysis·2025
Same author

Application of artificial intelligence to chronic kidney disease mineral bone disorder.

Clinical kidney journal·2024
Same author

Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease.

Frontiers in cardiovascular medicine·2023
Same author

When to initiate cancer screening exam?

Statistics and its interface·2022
Same author

Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.

Statistics and its interface·2022
Same journal

THE EFFECT OF BLOOD GLUCOSE ON QUIET STANDING BALANCE IN YOUNG HEALTHY INDIVIDUALS.

Biomedical engineering : applications, basis, and communications·2020
Same journal

THREE-DIMENSIONAL MULTI-SEGMENTED SPINE JOINT REACTION FORCES DURING COMMON WORKPLACE PHYSICAL DEMANDS/ACTIVITIES OF DAILY LIVING.

Biomedical engineering : applications, basis, and communications·2019
Same journal

MULTI-SEGMENTED TRUNK MOTION OF HEALTHY NON-ELDERLY ADULTS IN DIFFERENT DECADES OF LIFE.

Biomedical engineering : applications, basis, and communications·2019
Same journal

SIMULATION ANALYSIS OF BLOOD FLOW IN ARTERIES OF THE HUMAN ARM.

Biomedical engineering : applications, basis, and communications·2018
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.9K

Simplified Warfarin Dose-response Pharmacodynamic Models.

Seongho Kim1, Adam E Gaweda2, Dongfeng Wu3

  • 1Biostatistics Core, Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI.

Biomedical Engineering : Applications, Basis, and Communications
|March 10, 2015
PubMed
Summary
This summary is machine-generated.

Simplified models improve warfarin dosing personalization by offering comparable predictive ability to complex K-PD models but with greater parsimony. This research aids in developing more accessible personalized anticoagulation therapy.

Keywords:
dose-response modelkinetic-pharmacodynamicsmixed-effects modelstandard two-stage approach

More Related Videos

Comprehensive Analysis of Drug Response using the FLICK Assay
09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

909
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.9K
Comprehensive Analysis of Drug Response using the FLICK Assay
09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

909
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.5K

Area of Science:

  • Pharmacology
  • Pharmacometrics
  • Control Theory

Background:

  • Warfarin is a vital oral anticoagulant for preventing and treating thromboembolic events.
  • Personalized warfarin dosing is crucial due to its narrow therapeutic index and significant inter-individual variability.
  • Conventional kinetic-pharmacodynamic (K-PD) models are complex, hindering personalized dose management development.

Purpose of the Study:

  • To develop simplified pharmacokinetic-pharmacodynamic (PK-PD) models for warfarin dose-response relationships.
  • To apply these simplified models to patient data and compare their performance against conventional K-PD models.

Main Methods:

  • Proposed simplified pharmacodynamic (PD) models inspired by control theory principles.
  • Applied simplified and conventional K-PD models to longitudinal data from 37 patients.
  • Utilized a standard two-stage approach for model analysis and comparison.

Main Results:

  • All evaluated models demonstrated similar predictive capabilities for warfarin dosing.
  • The simplified PD models exhibited superior parsimony compared to conventional K-PD models.
  • This suggests simplified models are a viable alternative for personalized warfarin management.

Conclusions:

  • Simplified PD models offer a parsimonious and effective approach to understanding warfarin dose-response.
  • These models can facilitate the development of more accessible personalized anticoagulation strategies.
  • Further research into control theory-based models could enhance therapeutic drug management.